Q89
Conditions
Interventions
Group 1: It is a retrospective study design in which all the data to be analyzed are already available. The corresponding clinical and image files from the two external centers, the University Hospita
Sponsors
Klinikum der Universität München, Campus Großhadern
Eligibility
Sex/Gender
All
Age
5 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients diagnosed with arteriovenous or venous malformation of the hand and having undergone image-guided treatment by sclerotherapy or embolization in the form of one or more sessions during the period 01/01/2017 to 12/30/2020. - Patients who have received the above procedures with the following sclerotherapy/embolization agents: Polidocanol, gelled alcohol, EVOH-based liquid embolization agents (EVOH = ethylene vinyl alcohol copolymer).
Exclusion criteria
Exclusion criteria: - Patients with arteriovenous or venous malformation without involvement of the hand (wrist, metacarpal, finger). - Patients who have received the above procedures with sclerosing/embolizing agents elsewhere, e.g., bleomycin - Patients who have received otherwise image-guided interventional procedures, e.g., electrosclerotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analysis of the clinical success after image-guided, interventional treatment of arteriovenous and venous malformations (complete or partial symptom improvement, no symptom improvement, progress despite treatment) | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of the technical success after image-supported, interventional treatment of arteriovenous and venous malformations (successful execution of the interventions) | — |
Countries
Germany
Contacts
Public ContactSchmidt Vanessa
LMU München
Outcome results
None listed